Загрузка...
Palonosetron versus older 5-HT(3) receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis
BACKGROUND: No clinical standard currently exists for the optimal management of nausea induced by emetogenic chemotherapy, particularly delayed nausea. OBJECTIVE: To compare the efficacy and safety of palonosetron with older 5-HT(3) receptor antagonists (RAs) in preventing chemotherapy-induced nause...
Сохранить в:
| Опубликовано в: : | J Community Support Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734136/ https://ncbi.nlm.nih.gov/pubmed/25830233 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|